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Keywords: 
Introduction
The brain has a fully functional angiotensin system 
that mediates local generation of angiotensin II by the 
angiotensin-converting enzyme (Wright and Harding, 
2010). The renin-angiotensin system (RAS) in the 
brain is well known to be involved in systemic blood 
pressure control (de Gasparo et al., 2000). Some 
recent reports have shown that  this system has a 
Abstract 
Introduction: The brain renin-angiotensin system (RAS) has been reported having a 
pathological role in age-related impairment in learning and memory. Therefore, angiotensin 
converting enzyme inhibitors (ACEi) are expected to have positive effects on memory. Longtime 
treatment with captopril (an angiotensin converting enzyme inhibitor) signiﬁcantly attenuates the 
age-related impairment in learning and memory.  
Materials and Methods: In the present study, 24 month old male Wistar rats were divided into 
four experimental groups (n=8). Captopril treated groups received daily ip  injections of captopril 
at doses of 5, 10, 15 mg/kg/day for one week, the forth group served as control and remained 
untreated. Learning process was assessed by the reference memory task in the Morris water 
maze. All rats received water maze training (4 trials/day for 5 days) to assess hippocampal 
dependent spatial learning and then received a 60-s probe test of spatial memory retention 24 h 
after the 20th trial.  
Results: Over 5 days of training, captopril 5, 10, 15 mg/kg/day treatment signi ficantly reduced 
the latency and path length to finding the escape platform. In probe trails (without platform), on 
the last day of training, the captopril -treated group spent significantly longer time in the platform 
quadrant than control animals. Among treated group, 10 /mg/Kg dosage of captopril induced the 
best rehearsals memory.  
Conclusion: These results confirm the previous studies that ACEi have a positive influence on 
memory and it was noticeable that even short time treatment by captopril can improve spatial  
memory in the aged rats. 
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role in some additional functions in the central 
nervous system including regulation of cerebral blood 
flow and cerebral protection  against stress, 
depression, seizure, alcohol consumption and 
memory consolation, with possible role in the etiology 
of Alzheimer’s  and Parkinson  disease (De Bundel et
al., 2008; Mertens et al., 2010; Pelegrini-da-Silva et
al., 2009; Prozherina, 2008; Vanderheyden, 2009; 
Wright et al., 2008). Cognitive impairment and 
dementia are common serious health problems that 
impair quality of life in the elderly. Several lines of 
evidence suggest that learning and memory gradually 
decline with advancing age in humans (Albert, 1993; 
Beatty, 1988). This age-related impairment extends 
to spatial learning and memory tasks (Evans et al.,
1984; Light and Zelinski, 1983; Park et al., 1990; 
Sharps and Gollin, 1987; Weber et al., 1978). These 
age- related spatial learning and memory deﬁcits 
have been attributed to alterations in the connections 
and function of hippocampal formation (De Leon et
al., 1997; Squire, 1992). In the brain, the angiotensin-
converting enzyme is  overexpressed in the 
hippocampus, frontal cortex, and  caudate nucleus of 
both hemispheres in patients with dementia (Ohrui et
al., 2004). Previous reports indicate the possibility 
that treatment with antihypertensive agents can 
prevent the impairment of quality of life including 
cognitive performance(Fletcher, 1999; Fogari and 
Zoppi, 2004). Possible beneficial effects of RAS 
blockade on cognitive function are also being 
highlighted in the clinical field (Iwanami et al., 2009; 
Wright and Harding, 2010). The angiotensin receptor 
blockers (ARBs), which selectively prevent the
actions of AngII on receptors, are thought to have 
positive effects on cerebral blood flow and neuronal 
function (Maxwell and Hogan, 2010). An 
epidemiological study by Li et al. recently showed 
that male subjects treated with ARBs exhibited a 
significant reduction in the incidence and progression 
of Alzheimer disease (Li et al., 2010). A recent report 
in rat demonstrates that lifetime treatment with the 
antihypertensive drug captopril signiﬁcantly 
attenuates the age-related impairment in learning and 
memory by lowering arterial pressure (Wharton et al.,
2012; Wyss et al., 2000, 2003). But the interpretation 
of this beneﬁcial effect of ACE remains clouded. ACE 
inhibitors were also demonstrated to reverse the 
amnesic effects of electroconvulsive shock in a 
passive avoidance task in mice, directly improve 
passive avoidance learning and improve its retention 
with a 24-h delay in mice (Raghavendra et al., 2001) 
.But the nootropic effects of short time captopril 
treatment has been not  reported in spatial memory. 
In the present study, we employed captopril with 
three different dosages in a short time treatment 
model using Morris water maze task to assess its 
ability to improve spatial memory in the aged rats. 
Materials and methods 
Animals 
Twenty-four-month-old rats weighing 400–450 g were 
obtained from the Aging Farm, which was established 
at our animal house and used as the aged rats. The 
aged rats were produced by keeping them for 21 
months in the Aging Farm after purchase from the 
same breeder at 3 months old. They were housed 
two per cage in a temperature (23±1 °C) and light 
(12-h light/dark schedule; lights on at 8:00 am) 
controlled environment and were fed laboratory food 
and water ad libitum. All protocols for the experiments 
on animals were approved by the Research and 
Ethics Committee of Golestan University of Medical 
Sciences. Animals were randomly divided into 4 
groups of 8 animals in each, including control group 
and captopril 5, 10, 15 mg/Kg groups respectively. 
Captopril was purchased from Sigma–Aldrich, 
dissolved in saline and administrated intraperitonally 
at dose of 5, 10, 15 mg/kg to rats 60 min before 
Morris water maze task for 6 days.  
Morris water maze (MWM) task 
The MWM used in our study was a black circular pool 
(160 cm diameter, 60 cm high) filled with water 
(30 cm depth) at 24 ± 2 °C. The pool was divided into 
four quadrants arbitrarily deigned Northeast (NE), 
Northwest (NW), Southeast (SE) and Southwest 
(SW). A submerged plexiglas platform (10cm x 10cm) 
was hidden 1cm below the water surface and placed 
in a constant location in the center of NW quadrant. 
Animals received 5 days of training with the hidden 
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platform, each day included 4 training sessions with a 
60s intersession interval. Each trial was started by 
placing a rat with its face toward the wall of the pool 
at one of three start points. The start location was 
varied on each training trial and changed each day. 
The trial was terminated when the animal entered the 
platform. If the rat didn’t find the platform within 60s it 
was placed on the platform by the experimenter for 
15s. During acquisition of the spatial navigation task 
all groups were given one session of four trials each 
day (day 1-5; trial 1-20). Spatial memory was 
evaluated in the probe trial. On sixth day (trial 21), 
the platform was removed and animals were allowed 
to swim for 60s. The path of the animals in the maze 
was monitored using a computerized video tracking 
system (Maze router, urmia Instruments Inc). 
Parameters measured were the time taken to reach 
the platform (latency), swimming speed and swim 
path length (SPL) in the training trials. And during 
probe trials, the running time percentage within the 
quadrant of the water bath where the hidden platform 
had been placed in the training trials was calculated 
for each experimental animal. 
 
Statistical analysis 
Data were analyzed using SPSS 11.5 software and 
were plotted as mean ± SD. Comparison among the 
groups was made using analysis of variance 
(ANOVA) with a post hoc Tukey test or Repeated 
Measures ANOVA. Results were considered 
signiﬁcantly different when P<0.05 and highly 
signiﬁcantly different when P<0.01. 
Results 
Acquisition 
The escape latency and distance traveled by rats to 
finding the hidden platform in the water maze task are 
presented in Fig. 1A&B. The ability of all experimental 
animals to find the platform progressively was 
improved over the 5 days of acquisition (P<0.05). 
However, repeated ANOVA measures of these data 
revealed that the performance on this task was 
differed between the control and each of three 
captopril treated groups in the first four trial days 
(P<0.01). Inspection of the data in these days 
showed that animals in captopril treated groups 
learned the task at a high rate and traveled a shorter 
distance and spent less time to find the escape 
platform than control group (P < 0.01), but in the final 
trial day the escape latency and path length was 
similar in all experimental groups. Furthermore, there 
was no significant difference in these data among the 
groups receiving captopril in each trial day .The 
analysis of swimming speed by using two-way 
ANOVA also showed no significant difference as 
training days progressed among groups and no 
interaction between days and group (Fig. 1C). 
 
Probe trial 
Retention of the spatial training was assessed 24 h 
after the last training session with a 60 s free-swim 
probe trial using a new starting position. The 
parameters measured on the probe trial were time 
spent in the quadrant containing the platform during 
training (target quadrant). Post hoc analysis showed 
that the captopril treated groups showed significantly 
different experimental parameters from control ones 
(P<0.05). The captopril treated animals spent more 
time in the training quadrant compared to the control 
animals in the 60s probe trial (Fig. 2). In addition, 
among treated groups, the 10mg/ kg/day group spent 
more time in the training quadrant (P<0.05). Figure 3 
shows representative plots (top view) of individual 
swim paths of one rat for each treatment group and 
probe trial. In these examples, the start location was 
in the north–west quadrant of the pool, and the 
platform had formerly been located in the north–east 
quadrant of the pool (indicated by small circle for 
illustration purposes only; note that no platform was 
present in probe trials). 
Discussion  
There are now several lines of evidence suggesting 
angiotensin II (AII) may disrupt memory formation.  
Recent studies using specific antagonists of the 
angiotensin receptor (N. M. Barnes et al., 1990; 
Barnes et al., 1991) and angiotensin converting 
enzyme inhibitors that block the formation of AgII 
have shown these treatments can improve memory 
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Fig 1:  
Effect  of  short time   treatment  
with  captopril  (7 days) on  the   
performance  of spatial  memory  
acquisition  phase  in  Morris  water 
maze. Average scape latency (A), 
distance traveled (B), swimming 
speed (C) within each day (made 
up of four trials). Asterisks indicate 
a significant difference from control 
(*P < 0.05; **P < 0.01). 
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function in aged experimental animals  (Costall et al., 
1989; Flood and Morley, 1993; Mondadori and 
Etienne, 1990)  . In the present study we examined 
the effects of ACE inhibition on spatial memory in 
aged rats. Animals were treated for one week with 
three different doses of captopril, and their 
performance in a reference memory task-Morris water 
maze- was compared to controls. Rats treated with 5, 
10 and 15 mg/kg/day doses of captopril performed 
better than the control group in the water maze task. 
Latency and path length to finding the escape 
platform was significantly reduced in captopril treated 
animals. Surprisingly, in the first day of testing, 
captopril treated rats found the platform significantly 
faster than the control animals, and were consistently 
better at the task than control group up to fifth day 
 
and in the final trial day all rats found the platform in 
the similar time. In a probe trial, when the platform 
was removed from the pool, the captopril -treated 
group spend significantly longer time in the platform 
quadrant than control animals, demonstrating a better 
ability of remembering the position of the platform. 
Among treated group, 10 /mg/Kg dosage of captopril 
induced the best rehearsals memory. The positive 
effects of the ACEi treatment was reported previously 
in rat models of memory impairment in Morris water 
maze task in the diabetics rats (Jenkins and Chai, 
2007; Manschot et al., 2003; Wyss et al., 2003), four 
months treatment by enalapril from the onset of 
diabetes, significantly attenuated  memory 
impairment in the Morris water maze  tasks, 
compared to untreated-diabetics(Manschot et al., 
Fig 2: Water maze Mean (±SEM) percentage of time spent in target quadrant. Morris water maze during probe trials.  
Asterisks indicate a significant difference from control (*P < 0.05; **P < 0.01).  
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Fig 3: Tracings of the typical swim patterns in the probe trials (trial 21) at the control (A), captopril5 (B), 10 (C), 15 (D) 
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2003). Previous studies have  demonstrated that  
learning and memory decline happens during aging in 
the rat, especially between 12 and 24 months of 
age(Frick et al., 1995; Shukitt-Hale et al., 2004; van 
der Staay and de Jonge, 1993; Wyss et al., 2000). 
Furthermore, long-term administration of the ACE 
inhibitor captopril improved rat performance in the 
normotensive as well as hypertensive rats (Barnes et 
al.,1991). In this study we used 24month old rats but 
unlike the above mentioned researches, we 
administered captopril only for one week and like 
them, we have seen improvement of memory 
although for a much shorter captopril treatment time. 
In consistence of our results,  in  a habituation task in 
mice over 7 days, very low doses of the ACE 
inhibitors, captopril and ceranapril improved basal 
performance, reversed the impaired performance 
caused by the muscarinic receptor antagonist, 
scopolamine, and also improved the impaired 
performance of aged rats (Costall et al., 
1989).Surprisingly captopril in our data in  the first 
day of acquisition reduced the scape latency. This 
may suggest that an increase in cerebral perfusion is 
responsible for the immediate improvement of 
memory. Consistent with these findings, 
subcutaneous administration of a single dose of 
ramipril improved retention of a footshock  active 
avoidance task in STZ-diabetic mice (Zimmerman et 
al., 2002). Matin and colleague in their study 
purposed  captopril would alleviate cognitive function 
by improving endothelium dependent dilation of 
cerebral artery in the  hypertensive rats (Matin, 2014) 
. In contrast, Wyss and colleagues have not seen any 
improvement in the performance of young or aged 
SHRs treated with the anti-hypertensive drug, 
hydralazine in the Morris water maze task but they 
have reported in the last day all rats found scape 
platform in the same time  (Wyss et al., 2003) . So it 
seems that five day of training is enough for the old 
rats to find the scape platform even without need to 
captopril in probe trial and all groups of captopril 
treated rats spent more time in the target quadrant. It 
may represent the beneficial role of captopril in the 
memory rehearsal.  Among our captopril treated 
group, 10 /mg/Kg dosage of captopril showed the 
best rehearsals memory. Other studies have shown 
that more conventional doses of ACE inhibitors can 
significantly improve memory in different conditioned 
avoidance paradigms. Ramipril administration in a 
dose of 0.5-1.5 mg/kg improved retention when 
administered immediately after training in an active 
avoidance task in rats (Flood and Morley, 1993). ACE 
inhibitors were also demonstrated to reverse the 
amnesic effects of electroconvulsive shock in a 
passive avoidance task in mice (Mondadori and 
Etienne, 1990). It has also been shown that 
intracerebroventricular (i.c.v.) administration of  renin 
disrupts the learning of a passive avoidance 
response and this effect was antagonised by an ACE 
inhibitor as well as AT1 receptor antagonists, but not 
by an AT2 antagonist (DeNoble et al., 1991). 
Captopril  also might exert its effect without vascular 
action, for example by a direct effect on the brain 
neurotransmitters (Handa et al., 1991). Acetylcholine 
is one of the most important neurotransmitters 
involved in cognition and memory. Many studies have 
demonstrated a relation between memory deﬁcits and 
a decline in the cholinergic system function in the 
brain(Laursen et al., 2014; Lippa et al., 1980; 
Vanderheyden, 2009) . It has been  shown that  
scopolamine  can  prevent the memory -enhancing 
effect of Captopril, suggesting  that ACEIs, by 
preventing the formation of Ang II, may remove the 
inhibition of brain cholinergic system (J. M. Barnes et 
al., 1990). Neurohistochemical studies have shown 
that angiotensin II, in a concentration-dependent 
manner in rat tissue can inhibit potassium-stimulated 
release of acetylcholine from slices of rat entorhinal 
cortex. So, it has been  hypothesized that the 
potential cognitive enhancing properties of ACE 
inhibitors may reflect their role in preventing the 
formation of AT II and thus, remove an inhibitory 
modulatory effect of cholinergic function (J. M. 
Barnes et al., 1990). Angiotensin converting enzyme 
in the brain by hydrolyzing some neuropeptides, such 
as bradykinin, enkephalin and substance P,  might 
contribute in memory and learning processes 
(Hooper, N. M., Kenny A. and Turner A., J., 1985; 
Skidgel et al., 1984). Opposing effects have also 
been reported; when AT2 infused into hippocampus 
after training, Ang II produced a dose-dependent 
amnesic effect in the inhibitory avoidance task in rats, 
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which was blocked by the AT2 antagonist ,but not by 
the AT1 antagonist, losartan (Kerr et al., 2005). Our 
data indicate that short time captopril treatment can 
improve spatial memory in the aged rat in the water 
maze task and its immediate effect on memory 
probably is due to its effect on cerebral perfusion or 
its possible neuromodulatory effects. 
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